
Mycobacterium bovis BCG [21]


Matthias Groschel
Integrated Mycobacterial Pathogenomics
Tuberculosis (TB) affects mostly young people in their most productive years and the long treatment with its many side effects is a challenge for patients. A vaccine that protects better from developing TB or […]

Inhibitors of TMPK from Mycobacterium tuberculosis
Hélène Munier-Lehmann • Sylvie Pochet

Antibiotic resistances and drug screening
Brigitte Gicquel

Nanotherapeutics for Antibiotic Resistant Emerging Bacterial pathogens
Brigitte Gicquel

Nucleoside monophosphate kinases (NMPKs)
Hélène Munier-Lehmann

Giulia Manina
Microbial Individuality and Infection

Microbial Individuality and Infection
Giulia Manina

Dynamics of Host-Pathogen Interactions
Jost Enninga

Structural Microbiology
Pedro Alzari

Integrated Mycobacterial Pathogenomics
Roland Brosch

Roland Brosch
Integrated Mycobacterial Pathogenomics
Roland Brosch obtained his PhD at the University of Salzburg in Austria and after some years of postdoctoral training at the University of Wisconsin in Madison and the Institut Pasteur in Paris, he integrated […]

Jost Enninga
Dynamics of Host-Pathogen Interactions
Jost studied biochemistry at the University of Hannover and at the Medical School of Hannover (MHH), in Germany. For his Masters thesis and his Ph.D. studies, he joined the Laboratory of Cell Biology at […]

Brigitte Gicquel
Our team has developed genetic tools allowing the study of the biology of Mycobacterium tuberculosis. We developed the first methods using molecular biology for the rapid diagnosis of tuberculosis and study transmission. We isolated […]

Hélène Munier-Lehmann
Group: Biochemistry and chemobiology
My research interests are mainly focused on the structure-function relationships of macromolecules through multidisciplinary approaches. My studies have been concentrated on crucial enzymes belonging to the nucleotide metabolism, in particular nucleoside monophosphate kinases (NMPKs) […]
